Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...